Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CC618
Cat. No.:
0225LY-0876
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
CC618 serves as a selective antagonist for the PPARβ/δ receptor, yielding an IC50 of 10.0 μM.
Synonym:
1680204-90-3; 4-Methyl-2-[4-(trifluoromethyl)phenyl]-N-[2-[5-(trifluoromethyl)pyridin-2-yl]sulfonylethyl]-1,3-thiazole-5-carboxamide
CAS No.:
1680204-90-3
Compound CID:
118734332
Formula:
C20H15F6N3O3S2
Formula Weight:
523.47
Specification
Targets&IC50:
PPARβ/δ: 10.0 μM
Relative Density:
1.466 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
CC618 can be used in immunology research to explore the modulation of specific cytokine pathways.
Library Information
Target:
PPAR
Receptor:
PPARβ; PPARδ
Pathways:
Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-12
Plate Location:
c5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
55 mg/mL; 105.07 mM
